Loading...

Horwich Tamara

Title(s)Associate Professor, David Geffen School of Medicine at UCLA
Phone310-825-9011
vCardDownload vCard
    Other Positions
    Title(s)Associate Professor In-Residence, Cardiology


    Collapse Research 
    Collapse Research Activities and Funding
    Statins in Non-Ischemic Heart Failure: Potential Mechanisms of Benefit
    NIH/NHLBI K23HL085097Aug 1, 2007 - May 31, 2012
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Thomas E, Gupta PP, Fonarow GC, Horwich TB. Bioelectrical impedance analysis of body composition and survival in patients with heart failure. Clin Cardiol. 2019 Jan; 42(1):129-135. PMID: 30447075.
      View in: PubMed
    2. Horwich TB, Fonarow GC. Should I Participate in a Cardiac Rehabilitation Program? JAMA Cardiol. 2018 Nov 01; 3(11):1136. PMID: 30304406.
      View in: PubMed
    3. Horwich TB, Fonarow GC, Clark AL. Obesity and the Obesity Paradox in Heart Failure. Prog Cardiovasc Dis. 2018 Jul - Aug; 61(2):151-156. PMID: 29852198.
      View in: PubMed
    4. Chew KW, Liu CY, Ambale-Venkatesh B, Liao D, Horwich TB, Lima JAC, Bluemke DA, Paul Finn J, Butt AA, Currier JS. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons. J Int Med Res. 2017 Dec; 45(6):1693-1707. PMID: 28606026.
      View in: PubMed
    5. Chew KW, Bhattacharya D, Horwich TB, Yan P, McGinnis KA, Tseng C, Freiberg MS, Currier JS, Butt AA. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons. J Viral Hepat. 2017 10; 24(10):814-822. PMID: 28273386.
      View in: PubMed
    6. Zipursky RT, Press MC, Srikanthan P, Gornbein J, McClelland R, Watson K, Horwich TB. Relation of Stress Hormones (Urinary Catecholamines/Cortisol) to Coronary Artery Calcium in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol. 2017 06 15; 119(12):1963-1971. PMID: 28456316.
      View in: PubMed
    7. Lyons KJ, Bischoff MK, Fonarow GC, Horwich TB. Noninvasive Bioelectrical Impedance for Predicting Clinical Outcomes in Outpatients With Heart Failure. Crit Pathw Cardiol. 2017 03; 16(1):32-36. PMID: 28195941.
      View in: PubMed
    8. Chester RC, Gornbein JA, Hundley WG, Srikanthan P, Watson KE, Horwich T. Reflection Magnitude, a Measure of Arterial Stiffness, Predicts Incident Heart Failure in Men But Not Women: Multi-Ethnic Study of Atherosclerosis (MESA). J Card Fail. 2017 May; 23(5):353-362. PMID: 28104534.
      View in: PubMed
    9. Horwich TB, Fonarow GC. Prevention of Heart Failure. JAMA Cardiol. 2017 Jan 01; 2(1):116. PMID: 27926764.
      View in: PubMed
    10. Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, Jessup M, Kosiborod M, Pritchett AM, Ramasubbu K, Rosendorff C, Yancy C. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e535-e578. PMID: 27799274.
      View in: PubMed
    11. Motie M, Evangelista LS, Lombardo D, Hoi J, Horwich TB, Hamilton M, Fonarow GC. Effect of weight loss on renal function in overweight and obese patients with heart failure. Diabetes Metab Syndr. 2017 Apr - Jun; 11(2):95-98. PMID: 27381968.
      View in: PubMed
    12. Srikanthan P, Horwich TB, Tseng CH. Relation of Muscle Mass and Fat Mass to Cardiovascular Disease Mortality. Am J Cardiol. 2016 Apr 15; 117(8):1355-60. PMID: 26949037.
      View in: PubMed
    13. Belperio J, Horwich T, Abraham WT, Fonarow GC, Gorcsan J, Bersohn MM, Singh JP, Sonel A, Lee LY, Halilovic J, Kadish A, Shalaby AA. Inflammatory Mediators and Clinical Outcome in Patients With Advanced Heart Failure Receiving Cardiac Resynchronization Therapy. Am J Cardiol. 2016 Feb 15; 117(4):617-625. PMID: 26832186.
      View in: PubMed
    14. Christine PJ, Auchincloss AH, Bertoni AG, Carnethon MR, Sánchez BN, Moore K, Adar SD, Horwich TB, Watson KE, Diez Roux AV. Longitudinal Associations Between Neighborhood Physical and Social Environments and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA). JAMA Intern Med. 2015 Aug; 175(8):1311-20. PMID: 26121402.
      View in: PubMed
    15. Chew KW, Bhattacharya D, McGinnis KA, Horwich TB, Tseng CH, Currier JS, Butt AA. Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons. AIDS Res Hum Retroviruses. 2015 Jul; 31(7):718-22. PMID: 25858663; PMCID: PMC4505770.
    16. Ebong IA, Watson KE, Goff DC, Bluemke DA, Srikanthan P, Horwich T, Bertoni AG. Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis. Menopause. 2015 May; 22(5):527-33. PMID: 25290536; PMCID: PMC4387119.
    17. Horwich TB, Clark AL, Fonarow GC. Reply: To PMID 25465933. Am J Cardiol. 2015 Jul 01; 116(1):164-5. PMID: 25958113.
      View in: PubMed
    18. Clark AL, Fonarow GC, Horwich TB. Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure. Am J Cardiol. 2015 Jan 15; 115(2):209-13. PMID: 25465933.
      View in: PubMed
    19. Gupta PP, Fonarow GC, Horwich TB. Obesity and the obesity paradox in heart failure. Can J Cardiol. 2015 Feb; 31(2):195-202. PMID: 25661554.
      View in: PubMed
    20. Ebong IA, Watson KE, Goff DC, Bluemke DA, Srikanthan P, Horwich T, Bertoni AG. Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis. Menopause. 2014 Jun; 21(6):585-91. PMID: 24423934.
      View in: PubMed
    21. Motie M, Evangelista LS, Horwich T, Lombardo D, Zaldivar F, Hamilton M, Fonarow GC. Association between inflammatory biomarkers and adiposity in obese patients with heart failure and metabolic syndrome. Exp Ther Med. 2014 Jul; 8(1):181-186. PMID: 24944619.
      View in: PubMed
    22. Horwich TB, Tseng CH, Fonarow GC, Chyu J. Response to letter regarding article, "Four-variable risk model in men and women with heart failure". Circ Heart Fail. 2014 Mar 01; 7(2):381. PMID: 24779055.
      View in: PubMed
    23. Chyu J, Fonarow GC, Tseng CH, Horwich TB. Four-variable risk model in men and women with heart failure. Circ Heart Fail. 2014 Jan; 7(1):88-95. PMID: 24281135.
      View in: PubMed
    24. Clark AL, Fonarow GC, Horwich TB. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2014 Jan-Feb; 56(4):409-14. PMID: 24438732.
      View in: PubMed
    25. Kim JB, Hama S, Hough G, Navab M, Fogelman AM, Maclellan WR, Horwich TB, Fonarow GC. Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins. Am J Cardiol. 2013 Dec 01; 112(11):1770-7. PMID: 24050409.
      View in: PubMed
    26. Motie M, Evangelista LS, Horwich T, Hamilton M, Lombardo D, Cooper DM, Galassetti PR, Fonarow GC. Pro-HEART - a randomized clinical trial to test the effectiveness of a high protein diet targeting obese individuals with heart failure: rationale, design and baseline characteristics. Contemp Clin Trials. 2013 Nov; 36(2):371-81. PMID: 23958597; PMCID: PMC3844022.
    27. Cheng RK, DePasquale EC, Deng MC, Nsair A, Horwich TB. Obesity in heart failure: impact on survival and treatment modalities. Expert Rev Cardiovasc Ther. 2013 Sep; 11(9):1141-53. PMID: 23944985.
      View in: PubMed
    28. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):e240-327. PMID: 23741058.
      View in: PubMed
    29. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):1810-52. PMID: 23741057.
      View in: PubMed
    30. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15; 62(16):e147-239. PMID: 23747642.
      View in: PubMed
    31. Middlekauff HR, Verity MA, Horwich TB, Fonarow GC, Hamilton MA, Shieh P. Intact skeletal muscle mitochondrial enzyme activity but diminished exercise capacity in advanced heart failure patients on optimal medical and device therapy. Clin Res Cardiol. 2013 Aug; 102(8):547-54. PMID: 23575739; PMCID: PMC3710307.
    32. Loh JC, Creaser J, Rourke DA, Livingston N, Harrison TK, Vandenbogaart E, Moriguchi J, Hamilton MA, Tseng CH, Fonarow GC, Horwich TB. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center. Circ Heart Fail. 2013 May; 6(3):411-9. PMID: 23479563; PMCID: PMC3674961.
    33. Middlekauff HR, Vigna C, Verity MA, Fonarow GC, Horwich TB, Hamilton MA, Shieh P, Tupling AR. Abnormalities of calcium handling proteins in skeletal muscle mirror those of the heart in humans with heart failure: a shared mechanism? J Card Fail. 2012 Sep; 18(9):724-33. PMID: 22939042.
      View in: PubMed
    34. Clark AL, Chyu J, Horwich TB. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol. 2012 Jul 01; 110(1):77-82. PMID: 22497678; PMCID: PMC3377856.
    35. Buch E, Bradfield J, Larson T, Horwich T. Effect of bioimpedance body composition analysis on function of implanted cardiac devices. Pacing Clin Electrophysiol. 2012 Jun; 35(6):681-4. PMID: 22452409.
      View in: PubMed
    36. Tomova GS, Nimbal V, Horwich TB. Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus. Am J Cardiol. 2012 Jun 15; 109(12):1767-73. PMID: 22459300; PMCID: PMC3367080.
    37. Srikanthan P, Horwich TB. The obesity paradox: time for a new look at an old paradigm. Rev Esp Cardiol (Engl Ed). 2012 May; 65(5):403-4. PMID: 22406399.
      View in: PubMed
    38. Horwich TB, Broderick S, Chen L, McCullough PA, Strzelczyk T, Kitzman DW, Fletcher G, Safford RE, Ewald G, Fine LJ, Ellis SJ, Fonarow GC. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol. 2011 Dec 15; 108(12):1754-9. PMID: 21907317; PMCID: PMC3229667.
    39. Horwich TB, Middlekauff HR, Maclellan WR, Fonarow GC. Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial. J Card Fail. 2011 Nov; 17(11):879-86. PMID: 22041323; PMCID: PMC3206298.
    40. Clark AL, Fonarow GC, Horwich TB. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail. 2011 May; 17(5):374-80. PMID: 21549293.
      View in: PubMed
    41. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011 Jan; 8(1):30-41. PMID: 21060326; PMCID: PMC3033496.
    42. Sachdeva A, Horwich TB, Fonarow GC. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. Am J Cardiol. 2010 Sep 15; 106(6):830-5. PMID: 20816124.
      View in: PubMed
    43. Horwich TB, Fonarow GC. Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol. 2010 Jan 26; 55(4):283-93. PMID: 20117431; PMCID: PMC2834416.
    44. Shah DD, Fonarow GC, Horwich TB. Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. J Card Fail. 2010 Mar; 16(3):200-6. PMID: 20206893; PMCID: PMC2855621.
    45. Horwich TB, Leifer ES, Brawner CA, Fitz-Gerald MB, Fonarow GC. The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure. Am Heart J. 2009 Oct; 158(4 Suppl):S31-6. PMID: 19782786; PMCID: PMC2762950.
    46. Horwich T. Low-density lipoprotein in the setting of congestive heart failure: is lower really better? Curr Atheroscler Rep. 2009 Sep; 11(5):343-9. PMID: 19664377.
      View in: PubMed
    47. Horwich TB, Hernandez AF, Liang L, Albert NM, Labresh KA, Yancy CW, Fonarow GC. Weekend hospital admission and discharge for heart failure: association with quality of care and clinical outcomes. Am Heart J. 2009 Sep; 158(3):451-8. PMID: 19699870.
      View in: PubMed
    48. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009 Feb 10; 119(5):671-9. PMID: 19171851; PMCID: PMC2773290.
    49. Krantz MJ, Tanner J, Horwich TB, Yancy C, Albert NM, Hernandez AF, Dai D, Fonarow GC. Influence of hospital length of stay for heart failure on quality of care. Am J Cardiol. 2008 Dec 15; 102(12):1693-7. PMID: 19064026.
      View in: PubMed
    50. Cheng RK, Horwich TB, Fonarow GC. Relation of systolic blood pressure to survival in both ischemic and nonischemic systolic heart failure. Am J Cardiol. 2008 Dec 15; 102(12):1698-705. PMID: 19064027; PMCID: PMC2855695.
    51. Horwich TB, Hernandez AF, Dai D, Yancy CW, Fonarow GC. Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. Am Heart J. 2008 Dec; 156(6):1170-6. PMID: 19033015.
      View in: PubMed
    52. Horwich TB, Fonarow GC. Measures of obesity and outcomes after myocardial infarction. Circulation. 2008 Jul 29; 118(5):469-71. PMID: 18663098.
      View in: PubMed
    53. Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008 Jun 02; 101(11A):89E-103E. PMID: 18514634.
      View in: PubMed
    54. Horwich TB, Middlekauff HR. Potential autonomic nervous system effects of statins in heart failure. Heart Fail Clin. 2008 Apr; 4(2):163-70. PMID: 18433696; PMCID: PMC2440345.
    55. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008 May; 155(5):883-9. PMID: 18440336.
      View in: PubMed
    56. Fonarow GC, Peacock WF, Horwich TB, Phillips CO, Givertz MM, Lopatin M, Wynne J. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol. 2008 Jan 15; 101(2):231-7. PMID: 18178412.
      View in: PubMed
    57. Horwich TB, MacLellan WR. Atorvastatin and statins in the treatment of heart failure. Expert Opin Pharmacother. 2007 Dec; 8(17):3061-8. PMID: 18001265.
      View in: PubMed
    58. Horwich TB, Fonarow GC. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial. 2007 Nov-Dec; 20(6):549-53. PMID: 17991203.
      View in: PubMed
    59. Kalantar-Zadeh K, Kovesdy CP, Derose SF, Horwich TB, Fonarow GC. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol. 2007 Sep; 3(9):493-506. PMID: 17717562.
      View in: PubMed
    60. von Haehling S, Horwich TB, Fonarow GC, Anker SD. Tipping the scale: heart failure, body mass index, and prognosis. Circulation. 2007 Aug 07; 116(6):588-90. PMID: 17679626.
      View in: PubMed
    61. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, Morley JE. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007 Jul; 10(4):433-42. PMID: 17563461.
      View in: PubMed
    62. Afsarmanesh N, Horwich TB, Fonarow GC. Total cholesterol levels and mortality risk in nonischemic systolic heart failure. Am Heart J. 2006 Dec; 152(6):1077-83. PMID: 17161056.
      View in: PubMed
    63. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol. 2006 Jun 15; 97(12):1759-64. PMID: 16765130.
      View in: PubMed
    64. Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006 Mar; 26(2):118-33. PMID: 16530605.
      View in: PubMed
    65. Eshaghian S, Horwich TB, Fonarow GC. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J. 2006 Jan; 151(1):91. PMID: 16368297.
      View in: PubMed
    66. Horwich TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol. 2006 Jan 03; 47(1):85-90. PMID: 16386669.
      View in: PubMed
    67. Ralli S, Horwich TB, Fonarow GC. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. Am Heart J. 2005 Dec; 150(6):1220-7. PMID: 16338262.
      View in: PubMed
    68. Kalantar-Zadeh K, Anker SD, Coats AJ, Horwich TB, Fonarow GC. Obesity paradox as a component of reverse epidemiology in heart failure. Arch Intern Med. 2005 Aug 8-22; 165(15):1797; author reply 1797-8. PMID: 16087835.
      View in: PubMed
    69. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005 Mar; 81(3):543-54. PMID: 15755821.
      View in: PubMed
    70. Smooke S, Horwich TB, Fonarow GC. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J. 2005 Jan; 149(1):168-74. PMID: 15660049.
      View in: PubMed
    71. Horwich T, Foster E, De Marco T, Tseng Z, Saxon L. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices. J Cardiovasc Electrophysiol. 2004 Nov; 15(11):1284-9. PMID: 15574179.
      View in: PubMed
    72. Tiersten A, Wo J, Jacobson C, Weitzman A, Horwich T, Hesdorffer C, Savage D, Troxel A. Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer. Breast. 2004 Aug; 13(4):341-6. PMID: 15325671.
      View in: PubMed
    73. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004 Apr 21; 43(8):1439-44. PMID: 15093881.
      View in: PubMed
    74. Horwich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol. 2004 Feb 18; 43(4):642-8. PMID: 14975476.
      View in: PubMed
    75. Fonarow GC, Horwich TB. Cholesterol and mortality in heart failure: the bad gone good? J Am Coll Cardiol. 2003 Dec 03; 42(11):1941-3. PMID: 14662256.
      View in: PubMed
    76. Horwich T, Lee SJ, Saxon L. Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies. Am J Cardiol. 2003 Oct 01; 92(7):804-9. PMID: 14516880.
      View in: PubMed
    77. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation. 2003 Aug 19; 108(7):833-8. PMID: 12912820.
      View in: PubMed
    78. Fonarow GC, Horwich TB. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med. 2003; 4 Suppl 4:S20-8. PMID: 14564225.
      View in: PubMed
    79. Fonarow GC, Horwich TB. Prevention of heart failure: effective strategies to combat the growing epidemic. Rev Cardiovasc Med. 2003; 4(1):8-17. PMID: 12684599.
      View in: PubMed
    80. Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail. 2002 Aug; 8(4):216-24. PMID: 12397569.
      View in: PubMed
    81. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002 Jun 05; 39(11):1780-6. PMID: 12039491.
      View in: PubMed
    82. Horwich TB, Fonarow GC. Prevention of heart failure. Curr Cardiol Rep. 2002 May; 4(3):194-9. PMID: 11960587.
      View in: PubMed
    83. Horwich TB, Fonarow GC. The impact of obesity on survival in patients with heart failure. Heart Fail Monit. 2002; 3(1):8-14. PMID: 12634883.
      View in: PubMed
    84. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001 Sep; 38(3):789-95. PMID: 11527635.
      View in: PubMed